Fast-Acting Insulin Aspart Improves Glycemic Control in Basal-Bolus Treatment for Type 1 Diabetes: Results of a 26-Week Multicenter, Active-Controlled, Treat-to-Target, Randomized, Parallel-Group Trial (Onset 1)

Russell-Jones D, Bode BW, De Block C, Franek E, Heller SR, Mathieu C et al.
Diabetes Care. 2017 Jul;40(7):943-950.
doi: https://doi.org/10.2337/dc16-1771. Epub 2017 Mar 29.
Ver comentario

Comentado por la Dra. Karina Elgueta. Residente Diabetes del Adulto, Universidad de Chile